Correlation Between Cannassure Therapeutics and ICL Israel

Can any of the company-specific risk be diversified away by investing in both Cannassure Therapeutics and ICL Israel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannassure Therapeutics and ICL Israel into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannassure Therapeutics and ICL Israel Chemicals, you can compare the effects of market volatilities on Cannassure Therapeutics and ICL Israel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannassure Therapeutics with a short position of ICL Israel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannassure Therapeutics and ICL Israel.

Diversification Opportunities for Cannassure Therapeutics and ICL Israel

-0.74

Correlation Coefficient

Cannassure Therapeutics  ICL Israel

Pay attention - limited upside

The 3 months correlation between Cannassure and ICL is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Cannassure Therapeutics and ICL Israel Chemicals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ICL Israel Chemicals and Cannassure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannassure Therapeutics are associated (or correlated) with ICL Israel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ICL Israel Chemicals has no effect on the direction of Cannassure Therapeutics i.e., Cannassure Therapeutics and ICL Israel go up and down completely randomly.

Pair Corralation between Cannassure Therapeutics and ICL Israel

Assuming the 90 days trading horizon Cannassure Therapeutics is expected to under-perform the ICL Israel. In addition to that, Cannassure Therapeutics is 3.07 times more volatile than ICL Israel Chemicals. It trades about -0.03 of its total potential returns per unit of risk. ICL Israel Chemicals is currently generating about 0.25 per unit of volatility. If you would invest  164,389  in ICL Israel Chemicals on December 2, 2024 and sell it today you would earn a total of  54,611  from holding ICL Israel Chemicals or generate 33.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cannassure Therapeutics  vs.  ICL Israel Chemicals

Cannassure Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cannassure Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

ICL Israel Chemicals

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in ICL Israel Chemicals are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak essential indicators, ICL Israel sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cannassure Therapeutics and ICL Israel

The main advantage of trading using opposite Cannassure Therapeutics and ICL Israel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannassure Therapeutics position performs unexpectedly, ICL Israel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ICL Israel will offset losses from the drop in ICL Israel's long position.

The idea behind Cannassure Therapeutics and ICL Israel Chemicals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.